Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on December 14, 2017, covering events occurring on December 13, 2017. The Company, an emerging growth company incorporated in Delaware, operates in the health sector with a focus on equine athletes. The filing primarily addresses the entry into a material definitive agreement to expand its market presence in the Middle East and North Africa (MENA) region.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a contractual agreement rather than periodic financial performance data.
Material Changes and Agreements
On December 13, 2017, Jaguar Health entered into a collaboration agreement with Seed Mena Businessmen Services LLC ("SEED"), a Dubai-based entity affiliated with Seed Group. The agreement facilitates the distribution of Equilevia, the Company's non-prescription gut health product for equine athletes, within the UAE and the broader MENA region.
- Revenue Sharing: The Company will pay SEED 15% of total revenue generated from clients or partners introduced by SEED. This percentage increases to 20% after the first $1,000,000 of revenue is generated.
- Services: SEED will provide access to its existing network in the UAE and assist with legal and financial requirements.
- Term and Termination: The agreement is effective indefinitely but may be terminated by either party with 90 days' prior written notice. Termination may also occur due to material breach, untrue representations, or bankruptcy.
- Post-Termination Obligation: Upon termination for any reason, the Company remains obligated to make revenue sharing payments to SEED until the end of 2018.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance or specific management commentary regarding future earnings projections. The primary strategic outlook involves leveraging SEED's network to support business expansion in the MENA region. A key contingency is the ongoing obligation to pay revenue sharing fees through the end of 2018 even if the agreement is terminated early.
Investor Verification Checklist
- Verify the full text of the collaboration agreement with SEED, which is expected to be filed as an exhibit to the Company's Annual Report on Form 10-K for the year ended December 31, 2017.
- Review the press release dated December 14, 2017 (Exhibit 99.1) for additional details on the strategic partnership.
- Monitor future financial reports to assess the actual revenue generated from the MENA region and the associated 15-20% revenue sharing costs.
- Confirm the Company's status as an emerging growth company and its election not to use the extended transition period for new accounting standards.